Appendix 4E FY24 Preliminary Final Report
| Stock | Doctor Care Anywhere Group Plc (DOC.ASX) |
|---|---|
| Release Time | 27 Feb 2025, 9:33 a.m. |
| Price Sensitive | Yes |
Doctor Care Anywhere Delivers FY24 Results, Highlights Progress
- All 2024 market guidance met or exceeded
- 8.9% revenue growth (excluding secondary care pathway revenue)
- Gross margin improvement of 12.1ppt to 58.1%
Doctor Care Anywhere Group PLC has reported its Preliminary Full Year 2024 results, highlighting significant progress across the business. The company met or exceeded all of its 2024 market guidance, delivering 8.9% revenue growth (excluding secondary care pathway revenue), a 12.1ppt improvement in gross margin to 58.1%, and a £5.4m reduction in underlying EBITDA loss to £0.5m. These improvements were driven by the growing use of Advanced Clinical Practitioners, a shift to more 15-minute appointments, and higher revenue per consultation from annual price increases. The company also strengthened its leadership team, secured new client wins, and initiated a wider transformation programme to drive further process efficiencies and cost reduction. Doctor Care Anywhere ended the year in a strong financial position with £4.4m in cash and a £10.6m convertible loan facility, providing a solid foundation to support the company's path to profitability and positive cash flow.
The company expects to further reduce its non-operating costs in 2025 following the initiation of the company-wide transformation programme announced on 29 October 2024.
Doctor Care Anywhere is excited to share details of its opportunities to expand its customer base and commercial propositions, and thus materially grow revenue and profitability.